Michael Lassmann Selected Research

Michael Lassmann Research Topics

Disease

18	Thyroid Neoplasms (Thyroid Cancer) 10/2020 - 10/2003
17	Neoplasms (Cancer) 01/2022 - 03/2005
11	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2013
10	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2005
8	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 07/2016
4	Thyroid Diseases (Thyroid Disease) 09/2015 - 11/2010
2	Meningioma (Meningiomas) 01/2018 - 06/2012
2	Hyperthyroidism 01/2017 - 07/2013
2	Parkinson Disease (Parkinson's Disease) 01/2015 - 01/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2013 - 04/2007
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Infections 07/2021
1	Neuroblastoma 03/2020
1	Pain (Aches) 11/2019
1	Papillary Thyroid Cancer 06/2016
1	Multiple Myeloma 02/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Lymphoma (Lymphomas) 01/2015
1	Essential Tremor (Essential Tremors) 01/2015
1	Parkinsonian Disorders (Parkinsonism) 01/2015
1	Graves Disease (Basedow Disease) 07/2013
1	Hypersensitivity (Allergy) 11/2011
1	Hypothyroidism 08/2011
1	Nausea 05/2010
1	Sialadenitis 05/2010
1	Vomiting 05/2010
1	Squamous Cell Carcinoma of Head and Neck 11/2009
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2007
1	Ankylosing Spondylitis 09/2002

Drug/Important Bio-Agent (IBA)

9	Radioisotopes (Radionuclides)IBA 07/2019 - 01/2006
6	Peptide Receptors (Peptide Receptor)IBA 01/2017 - 06/2012
5	IodineIBA 08/2018 - 10/2003
4	Chemokine ReceptorsIBA 01/2022 - 02/2016
4	RadiopharmaceuticalsIBA 11/2019 - 07/2014
4	AntigensIBA 11/2019 - 06/2015
4	Thyrotropin Alfa FDA LinkGeneric 08/2011 - 03/2005
4	Thyroid HormonesIBA 08/2011 - 10/2003
3	68Ga-pentixaforIBA 01/2017 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2017
2	Hormones (Hormone)IBA 07/2021 - 04/2006
2	PSMA I&TIBA 02/2020 - 08/2015
2	LigandsIBA 11/2019 - 01/2015
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2019 - 02/2016
2	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 02/2016
2	Iodine-131IBA 06/2019 - 08/2018
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019 - 01/2017
2	Edotreotide (SMT 487)IBA 01/2018 - 01/2017
2	Peptides (Polypeptides)IBA 01/2018 - 11/2016
2	gallium 68 PSMA-11IBA 08/2015 - 06/2015
2	ibritumomab tiuxetan (Zevalin)FDA Link 03/2013 - 04/2007
1	IsotopesIBA 01/2022
1	90Y-pentixatherIBA 01/2022
1	Radium-223IBA 01/2022
1	Biological ProductsIBA 10/2021
1	ElectrolytesIBA 07/2021
1	VitaminsIBA 07/2021
1	3-Iodobenzylguanidine (Iobenguane)IBA 03/2020
1	177Lu-DOTA-JR11IBA 01/2019
1	2'-deoxyguanosine 5'-phosphate (dGMP)IBA 08/2018
1	DOTA(0)-Tyr(3)- 177Lu-octreotideIBA 01/2018
1	lutetium Lu 177 dotatateIBA 01/2018
1	Gallium-68IBA 01/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018
1	Lutetium-177IBA 01/2018
1	Fluorine-18IBA 01/2018
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	ProdrugsIBA 01/2017
1	aluminum fluorideIBA 11/2016
1	(18)F-PSMA-11IBA 11/2016
1	Choline (Choline Chloride)IBA 07/2016
1	ChemokinesIBA 01/2015
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2015
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2015
1	RadiumIBA 07/2014
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Immunoconjugates (Immunoconjugate)IBA 03/2013
1	Octreotide (Sandostatin)FDA LinkGeneric 06/2012
1	Rituximab (Mabthera)FDA Link 04/2007
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2003
1	ChloridesIBA 09/2002

Therapy/Procedure

27	Therapeutics 01/2022 - 09/2002
6	Castration 01/2022 - 01/2013
3	Radiotherapy 02/2016 - 06/2012
2	Stem Cell Transplantation 01/2022 - 02/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 02/2016
2	Precision Medicine 01/2017 - 01/2017
1	Gamma Cameras (Gamma Camera) 01/2017
1	Microspheres (Microsphere) 07/2014
1	Off-Label Use 08/2011
1	Immunotherapy 04/2007